logo

For the Inventor, By the Inventor

Sakai, Japan

Kohji Hattori

This inventor holds 13 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1989-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kohji Hattori. Retrieved from https://idiyas.com/inventor/kohji-hattori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 100.0

Average Co-Inventor Count = 5.2

ph-index = 8

Forward Citations = 169(Granted Patents)


Location History:

  • Osaka, JP (1991)
  • Nagoya, JP (1994)
  • Sakai, JP (1989 - 1995)
  • Takarazuka, JP (1997)

Company Filing History:

goldMedal13 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents

Years Active: 1989-1997

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5608056 - Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents (1997-03-04),
2. 5420122 - 3-pyrrolidinylthio-1-azabicyclo-[3.2.0]hept-2-ene-2-carboxylic acid (1995-05-30),
3. 5286721 - 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds (1994-02-15),
4. 5202437 - 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid (1993-04-13),
5. 5194624 - Intermediates for the preparation of compounds of antimicrobial activity (1993-03-16),
6. 5138064 - 3-Pyrrolidinylthio-1-azabicyclo-[3.2.0]hept-2-ene-2-carboxylic acid (1992-08-11),
7. 5102877 - 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds (1992-04-07),
8. 4983596 - 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid (1991-01-08),
9. 4963544 - 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid (1990-10-16),
10. 4963543 - 3-pyrolidinylthio-1-azabicyclo-[3.2.0]hept-2-ene-2-carboxylic acid (1990-10-16),
11. 4925838 - 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid (1990-05-15),
12. 4921852 - 3-pyrrolidinylthio-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (1990-05-01),
13. 4822787 - 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid (1989-04-18),

Title: Kohji Hattori: Innovator in Antimicrobial Agents

Introduction

Kohji Hattori, a notable inventor based in Sakai, Japan, has made significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, Hattori's work primarily focuses on antimicrobial agents, showcasing his dedication to enhancing medical treatments for infectious diseases.

Latest Patents

Among his latest innovations, Hattori has developed substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents. His patented compounds, including 3-pyrrolidinylthio-1-azabicyclo-[3.2.0]hept-2-ene-2-carboxylic acid, demonstrate promising antimicrobial activity. These novel compounds not only showcase significant potential for use as medicaments but also play a vital role in treating infectious diseases in both humans and animals. The processes for their preparation form a crucial part of Hattori's contributions to modern medicine.

Career Highlights

Kohji Hattori has established himself within the esteemed Fujisawa Pharmaceutical Company, Ltd., where his innovative spirit has led to numerous breakthroughs in the development of antimicrobial therapies. His dedication to research and innovation has earned him recognition in the pharmaceutical community.

Collaborations

Throughout his career, Hattori has worked alongside notable colleagues such as Masayoshi Murata and Hideo Tsutsumi. These collaborations underline the importance of teamwork in driving forward scientific advancements and enhancing the impact of their collective research on public health.

Conclusion

In conclusion, Kohji Hattori stands out as a prominent inventor dedicated to the innovation of antimicrobial agents. His substantial portfolio of patents and collaborative efforts highlight his commitment to advancing medical science. With ongoing research and development, Hattori's inventions are poised to make a lasting impact on the treatment of infectious diseases globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…